Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma.

Lin CH, Li HY, Liu YP, Kuo PF, Wang WC, Lin FC, Chang WL, Sheu BS, Wang YC, Hung WC, Cheng HC, Yao YC, Calkins MJ, Hsiao M, Lu PJ.

Ther Adv Med Oncol. 2019 Sep 27;11:1758835919875324. doi: 10.1177/1758835919875324. eCollection 2019.

2.

Modulation of UVB-induced Carcinogenesis by Activation of Alternative DNA Repair Pathways.

Sha Y, Vartanian V, Owen N, Mengden Koon SJ, Calkins MJ, Thompson CS, Mirafzali Z, Mir S, Goldsmith LE, He H, Luo C, Brown SM, Doetsch PW, Kaempf A, Lim JY, McCullough AK, Lloyd RS.

Sci Rep. 2018 Jan 15;8(1):705. doi: 10.1038/s41598-017-17940-8.

3.

miR-105/93-3p promotes chemoresistance and circulating miR-105/93-3p acts as a diagnostic biomarker for triple negative breast cancer.

Li HY, Liang JL, Kuo YL, Lee HH, Calkins MJ, Chang HT, Lin FC, Chen YC, Hsu TI, Hsiao M, Ger LP, Lu PJ.

Breast Cancer Res. 2017 Dec 19;19(1):133. doi: 10.1186/s13058-017-0918-2.

4.

Mitochondrial defects arise from nucleoside/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders.

Hung KM, Chen PC, Hsieh HC, Calkins MJ.

Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):406-413. doi: 10.1016/j.bbadis.2016.11.017. Epub 2016 Nov 11.

5.

Enhanced sensitivity of Neil1-/- mice to chronic UVB exposure.

Calkins MJ, Vartanian V, Owen N, Kirkali G, Jaruga P, Dizdaroglu M, McCullough AK, Lloyd RS.

DNA Repair (Amst). 2016 Dec;48:43-50. doi: 10.1016/j.dnarep.2016.10.010. Epub 2016 Oct 28.

6.

MiR-193a-5p/ERBB2 act as concurrent chemoradiation therapy response indicator of esophageal squamous cell carcinoma.

Lin CH, Tsai CH, Yeh CT, Liang JL, Hung WC, Lin FC, Chang WL, Li HY, Yao YC, Hsu TI, Lee YC, Wang YC, Sheu BS, Lai WW, Calkins MJ, Hsiao M, Lu PJ.

Oncotarget. 2016 Jun 28;7(26):39680-39693. doi: 10.18632/oncotarget.9444.

7.

Mitochondrial homeostatic disruptions are sensitive indicators of stress in neurons with defective mitochondrial DNA transactions.

Hung KM, Calkins MJ.

Mitochondrion. 2016 Nov;31:9-19. doi: 10.1016/j.mito.2016.08.015. Epub 2016 Aug 28.

PMID:
27581214
8.

CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient.

Chen YC, Li HY, Liang JL, Ger LP, Chang HT, Hsiao M, Calkins MJ, Cheng HC, Chuang JH, Lu PJ.

Oncotarget. 2017 May 2;8(18):29699-29710. doi: 10.18632/oncotarget.10719.

9.

Exercise Counteracts Aging-Related Memory Impairment: A Potential Role for the Astrocytic Metabolic Shuttle.

Tsai SF, Chen PC, Calkins MJ, Wu SY, Kuo YM.

Front Aging Neurosci. 2016 Mar 22;8:57. doi: 10.3389/fnagi.2016.00057. eCollection 2016. Review.

10.

Huntingtin-Interacting Protein-1 Is an Early-Stage Prognostic Biomarker of Lung Adenocarcinoma and Suppresses Metastasis via Akt-mediated Epithelial-Mesenchymal Transition.

Hsu CY, Lin CH, Jan YH, Su CY, Yao YC, Cheng HC, Hsu TI, Wang PS, Su WP, Yang CJ, Huang MS, Calkins MJ, Hsiao M, Lu PJ.

Am J Respir Crit Care Med. 2016 Apr 15;193(8):869-80. doi: 10.1164/rccm.201412-2226OC.

PMID:
26595459
11.

Stem cell transplantation therapy in Parkinson's disease.

Fu MH, Li CL, Lin HL, Chen PC, Calkins MJ, Chang YF, Cheng PH, Yang SH.

Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015. Review.

12.

Landscape of Pin1 in the cell cycle.

Lin CH, Li HY, Lee YC, Calkins MJ, Lee KH, Yang CN, Lu PJ.

Exp Biol Med (Maywood). 2015 Mar;240(3):403-8. doi: 10.1177/1535370215570829. Epub 2015 Feb 7. Review.

13.

Inhibition of DNA glycosylases via small molecule purine analogs.

Jacobs AC, Calkins MJ, Jadhav A, Dorjsuren D, Maloney D, Simeonov A, Jaruga P, Dizdaroglu M, McCullough AK, Lloyd RS.

PLoS One. 2013 Dec 9;8(12):e81667. doi: 10.1371/journal.pone.0081667. eCollection 2013.

14.
15.

Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

Mao P, Manczak M, Calkins MJ, Truong Q, Reddy TP, Reddy AP, Shirendeb U, Lo HH, Rabinovitch PS, Reddy PH.

Hum Mol Genet. 2012 Jul 1;21(13):2973-90. doi: 10.1093/hmg/dds128. Epub 2012 Apr 5.

16.

Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics.

Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, Manczak M.

Biochim Biophys Acta. 2012 May;1822(5):639-49. doi: 10.1016/j.bbadis.2011.10.011. Epub 2011 Oct 19. Review.

17.

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH.

Hum Mol Genet. 2012 Jan 15;21(2):406-20. doi: 10.1093/hmg/ddr475. Epub 2011 Oct 13.

18.

Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.

Calkins MJ, Manczak M, Mao P, Shirendeb U, Reddy PH.

Hum Mol Genet. 2011 Dec 1;20(23):4515-29. doi: 10.1093/hmg/ddr381. Epub 2011 Aug 25.

19.
20.

Supplemental Content

Loading ...
Support Center